amgn htm document united statessecurities exchange commissionwashington amendment mark one annual report pursuant section security exchange act of the fiscal year ended december or transition report pursuant to section or of the security exchange act of file number amgen inc exact name of registrant specified charter delaware state or jurisdiction ofincorporation or organization employeridentification no one amgen center drive oak california address of principal executive office zip code registrant telephone number including area code security registered pursuant to section of the act title of classtrading symbol name of each exchange registeredcommon stock par valueamgnthe nasdaq global select senior note due york stock senior note due york stock exchangesecurities registered pursuant to section of the act noneindicate check mark the registrant well known seasoned issuer defined in rule of the security act yes no indicate by check mark if the registrant is required to file report pursuant to section or section of the act yes no ýindicate by check mark whether the registrant filed report required to filed by section or section of the security exchange act of the preceding month or shorter period the registrant required to file such report and ha subject to such filing requirement for the past day yes no indicate by check mark whether the registrant ha submitted electronically every interactive data file required to be submitted pursuant to rule of regulation of chapter during the preceding month or for such shorter period that the registrant wa required to submit such file yes no indicate by check mark whether the registrant is large accelerated filer accelerated filer non accelerated filer smaller reporting company or an emerging growth company see the definition of large accelerated filer accelerated filer smaller reporting company and emerging growth company in rule of the exchange act large accelerated fileraccelerated filernon accelerated filersmaller reporting company emerging growth company if an emerging growth company indicate by check mark if the registrant ha elected not to use the extended transition period for complying new or revised financial accounting standard provided pursuant to section of the exchange act indicate by check mark whether the registrant is shell company defined in rule of the act yes no ýthe approximate aggregate market value of voting and non voting stock held by non affiliate of the registrant wa of june excludes share of common stock held by director and executive officer and any stockholder whose ownership exceeds ten percent of the share outstanding june exclusion of share held by any person not be construed to indicate that such person posse the power directly or indirectly to direct or cause the direction of the management or policy of the registrant or that such person is controlled by or common control with the registrant number of share of common stock outstanding of february document incorporated by referencespecified portion of the registrant proxy statement with respect to the annual meeting of stockholder to be held may incorporated by reference part iii of this annual report explanatory notethis amendment no to the annual report on form of amgen inc the company for the year ended december filed with the security and exchange commission on february the original form is filed for the sole purpose of inserting the conformed signature of ernst young llp the company independent auditor which wa inadvertently omitted the original form except otherwise expressly noted herein this amendment no not modify or update in any way the financial position result of operation cash flow or other disclosure in or exhibit to the original form doe reflect event occurring the filing of the original form accordingly this amendment no should be read in conjunction with the original form index to exhibitsexhibit no rule certification section certification report of independent registered public accounting firmto the board of director and stockholder of amgen inc opinion on the financial statement audited the accompanying consolidated balance sheet of amgen inc the company of december and the related consolidated statement of income comprehensive income stockholder equity and cash flow for each of the three year in the period ended december and the related note and the financial statement schedule listed in the index at item collectively referred to the consolidated financial statement in opinion the consolidated financial statement present fairly in all material respect the financial position of the company at december and and the result of it operation and it cash flow for each of the three year in the period ended december in conformity with generally accepted accounting principle we also have audited in accordance with the standard of the public company accounting oversight board united state pcaob the company internal control financial reporting of december based on criterion established in internal control integrated framework issued by the committee of sponsoring organization of the treadway commission framework and our report dated february expressed an unqualified opinion thereon basis for opinion financial statement are the responsibility of the company management our responsibility is to express an opinion on the company financial statement based on our audit we are public accounting firm registered with the pcaob and are required to be independent with respect to the company in accordance with the federal security law and the applicable rule and regulation of the security and exchange commission and the pcaob we conducted our audit in accordance with the standard of the pcaob standard require that we plan and perform the audit to obtain reasonable assurance whether the financial statement are free of material misstatement whether due to error or fraud our audit included performing procedure to ass the risk of material misstatement of the financial statement whether due to error or fraud and performing procedure that respond to those risk such procedure included examining on test basis evidence regarding the amount and disclosure in the financial statement our audit also included evaluating the accounting principle used and significant estimate made by management well evaluating the overall presentation of the financial statement we believe that our audit provide reasonable basis for our opinion critical audit mattersthe critical audit matter communicated are matter arising from the current period audit of the financial statement that communicated or required to be communicated to the audit committee and that relate to account or disclosure that are material to the financial statement and involved our especially challenging subjective or complex judgment the communication of critical audit matter doe not alter in any way our opinion on the financial statement taken whole and we are not by communicating the critical audit matter below providing separate opinion on the critical audit matter or on the account or disclosure to which relate sale deduction description of the matteras of december the company recorded accrued sale deduction of billion described in note to the financial statement under the caption product sale and sale deduction revenue from product sale are recognized net of accrual for estimated rebate wholesaler chargebacks discount and other deduction collectively sale deduction which are established at the time of sale auditing the estimation of sale deduction which are netted product sale is complex requires significant judgment and the amount involved are material to the financial statement taken whole revenue from product sale is recognized upon transfer of control of product to customer generally upon delivery and is based on an amount that reflects the consideration to which the company expects to be entitled which represents an amount that is net of accrual for estimated sale deduction the estimated sale deduction are based on current contractual and statutory requirement market event and trend internal and external historical data and forecasted customer buying pattern we addressed the matter in our auditwe obtained an understanding evaluated the design and tested the operating effectiveness of internal control over the sale deduction process this included testing control over management review of significant assumption and input used in the estimate of sale deduction including actual sale contractual term historical experience wholesaler inventory level demand data and estimated patient population we also tested management control over the accuracy of forecasting demand activity well the completeness and accuracy of all other component included in the final sale deduction estimate to test management estimated sale deduction we obtained management calculation for the respective estimate and performed the following procedure among others we tested management estimation process over the determination of sale discount accrual by developing an independent expectation of the estimated accrual rate including comparison of rate used in management forecast to rate in the underlying contract performing lookback analysis using actual historical data to evaluate the forecasted amount assessing subsequent event to determine whether wa any new information that would require adjustment to the initial accrual evaluating trend in actual sale and discount accrual balance comparing cash receipt to product sale confirming term and condition for sample of contract with the company customer testing sample of credit issued and payment made throughout the year and agreeing rate to underlying contract term unrecognized tax benefit description of the matteras discussed in note and to the consolidated financial statement the company operates in various jurisdiction in which differing interpretation of complex tax law and regulation create uncertainty and necessitate the use of significant judgment in the determination of the company unrecognized tax benefit related to allocation of profit among various jurisdiction transfer pricing particularly in the federal tax jurisdiction the company ha significant asset and operation in this regard the company us significant judgment in determining whether tax position technical merit are likely not to be sustained and measuring the amount of tax benefit that qualifies for recognition of december the company accrued billion of gross unrecognized tax benefit including transfer pricing auditing the assessment of the technical merit and measurement of the company unrecognized tax benefit is challenging they be complex highly judgmental and based on interpretation of tax law and regulation how we addressed the matter in our auditwe obtained an understanding evaluated the design and tested the operating effectiveness of internal control over the company process to ass the technical merit of it tax position well management process to measure the unrecognized tax benefit of those tax position particularly in regard to transfer pricing this included testing control over management review of the input calculation assumption and method selected to measure the amount of tax benefit that qualify for recognition we involved tax and transfer pricing professional to assist in assessing the technical merit and measurement of certain of the company unrecognized tax benefit depending on the nature of the specific tax position and applicable development with the relevant tax authority our procedure included obtaining and reviewing the company correspondence with such tax authority and evaluating certain third party advice to support the company evaluation and recorded position we used our knowledge of and experience with how the income tax law and regulation related to transfer pricing are applied by the relevant tax authority to evaluate the company accounting for it unrecognized tax benefit we evaluated development in the applicable regulatory environment to ass potential effect on the company recorded position we analyzed the assumption and data used by the company it determined the amount of tax benefit to recognize including applicable interest and penalty and we tested the accuracy of those underlying calculation we have also evaluated the company income tax disclosure included in note in relation to these matter ernst young llpwe have served the company auditor since los angeles californiafebruary to the requirement of the security exchange act of the registrant ha duly caused this annual report to be signed on it behalf by the undersigned thereunto duly authorized amgen inc registrant date february peter griffith peter griffith executive vice president and chief financial officer principal financial and accounting officer